Nanexa AB (publ)

Stockholm Stock Exchange NANEXA.ST

Nanexa AB (publ) Dividend Per Share for the year ending December 31, 2023: USD -0.00

Nanexa AB (publ) Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Nanexa AB (publ) Dividend Per Share for the year ending December 31, 2022 was USD -0.00, a 0.00% change year over year.
Nanexa AB (publ) Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a 0.00% change year over year.
Nanexa AB (publ) Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
Nanexa AB (publ) Dividend Per Share for the year ending December 31, 2019 was USD -0.00, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

Stockholm Stock Exchange: NANEXA.ST

Nanexa AB (publ)

CEO	Mr. David Westberg
IPO Date	June 17, 2015
Location	Sweden
Headquarters	Virdings AllE 32B
Employees	19
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.

Key trends

Past 5 years